FIRAS HIJAZI: Open Payments
NPI 1962415943 · LAPLACE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 35 payments from 11 companies in 2025. Trend: 2023 $953 · 2024 $974 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $150 |
| Collegium Pharmaceutical, Inc. | 8 | $148 |
| Medtronic, Inc. | 1 | $124 |
| SCILEX PHARMACEUTICALS INC. | 5 | $95 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| ABBVIE INC. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| PFIZER INC. | 3 | $53 |
| Virtus Pharmaceuticals LLC | 2 | $46 |
| Valinor Pharma, LLC | 2 | $29 |
Products named: Clinical Trial Product, MAZOR X SYSTEM, ZTLido, Symbravo, Belbuca, XTAMPZA, RELISTOR, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
